3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Node-positive Breast Cancer: new trials by email Literature Review of Node-positive Breast Cancer trials Research Report on Node-positive Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer Neoadjuvant Pembrolizumab, low dose neoadjuvant boost, High dose neoadjuvant boost - Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 32 | 2026-03-17 | 2026-04-27 |
| Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer CT Scan - Breast Cancer, Node-positive Breast Cancer | Phase 2 | Recruiting | H. Lee Moffitt Cancer Center and Research Institute | 120 | 2025-02-24 | 2026-07-02 |
| Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer Hypofractionated radiation, Ultra-hypofractionated breast/chest wall and regional nodal radiation - Node-positive Breast Cancer | Phase 2 | Recruiting | Washington University School of Medicine | 220 | 2024-08-27 | 2026-01-09 |
Breast Neoplasms (3) · Triple Negative Breast Neoplasms (1)
Breast Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3)
Radiation Dose Hypofractionation (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · UNC Lineberger Comprehensive Cancer Center (1) · Washington University School of Medicine (1)
United States (3)
Dana Casey, MD (1) · Kamran Ahmed (1) · Maria Thomas, M.D., Ph.D. (1) · Matthew Mills (1)
R01CA274254 (1)